Latest Industry Insights

Technology Networks spoke to Stefan Baier, head of food science at Motif FoodWorks, to learn more about the exclusive access to transformative plant-based food technologies the company has recently been granted. He also highlights the role plant-based foods play in protecting the environment and the importance of flavor and texture when developing plant-based foods.

Clinicians have been using AMH in treatments related to reproductive health for over 20 years. High-quality diagnostic assays have come on in leaps and bounds over that time, continuing to provide precise insights to support clinical decisions made in the areas of reproductive aging, fertility and pregnancy monitoring.

In this interview, Sudharshan Rangarajan discusses how laboratories can overcome some of the hurdles of incorporating automation into their workflow and highlights some of the solutions that Thermo Fisher Scientific offers in this space.

Multi-dimensional insights into the effects of drugs on protein structure and function can help de-risk the drug discovery process, building confidence in new drug candidates and their mechanism of action before moving on to the next more costly stage of development.

In the search to discover new therapeutic approaches for AD, scientists are finding new inspiration where others may have never thought to look: cancer research trends.

Many of us are familiar with the undesirable physical and mental effects of a disrupted sleep/wake cycle caused by traveling across multiple time zones or working irregular hours. A collaborative project designed to address these issues is working to develop a “living pharmacy” – a personalized, wireless and fully implantable device that can control the body’s circadian clock.

In this article, we outline how researchers at the University of Maastricht have used a novel spatial omics workflow to uncover proteomic profiles in tumor subpopulations of breast cancer.

Technology Networks recently spoke with Jean-François Bellec, ProteinSimple applications scientist, to learn about Bio-Techne’s history and how its solutions enable researchers to work efficiently and ensure accuracy in their experiments. In this interview, Jean-François also highlights how the company’s offerings have supported researchers throughout the COVID-19 pandemic.

A new body of work published in Science Translational Medicine outlines the preclinical testing of a microRNA-based gene therapy for Huntington's disease – AMT-130 – in minipigs.

Progenity’s Christopher Wahl provides his insights into the research and work being done specifically with Progenity’s novel ingestible lab-in-a-capsule, PIL Dx.